There were 138 press releases posted in the last 24 hours and 448,027 in the last 365 days.


Please use this form to send email to PR contact of this press release:
InterveXion Enrolls First Patient in OUTLAST, a Phase 2 Study of IXT-m200 in Methamphetamine Use Disorder

Misty Stevens
InterveXion Therapeutics


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image